Depletion of protein kinase Cepsilon in normal and scleroderma lung fibroblasts has opposite effects on tenascin expression
To determine whether the extracellular matrix protein tenascin-C (TN-C) is overexpressed in lung fibroblasts from systemic sclerosis (SSc) patients, the molecular mechanisms regulating TN-C secretion in SSc and normal lung fibroblasts, and how these processes might contribute to lung fibrosis in SSc...
Saved in:
| Published in | Arthritis and rheumatism Vol. 44; no. 6; p. 1370 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
01.06.2001
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0004-3591 |
| DOI | 10.1002/1529-0131(200106)44:6<1370::AID-ART230>3.0.CO;2-2 |
Cover
| Abstract | To determine whether the extracellular matrix protein tenascin-C (TN-C) is overexpressed in lung fibroblasts from systemic sclerosis (SSc) patients, the molecular mechanisms regulating TN-C secretion in SSc and normal lung fibroblasts, and how these processes might contribute to lung fibrosis in SSc patients.
TN-C secretion by SSc and normal fibroblasts was compared in vivo (in bronchoalveolar lavage [BAL] fluid) and in vitro (in culture medium). The ability of thrombin to induce TN-C was confirmed at both the protein and the messenger RNA (mRNA) level. The role of protein kinase Cepsilon (PKCepsilon) in the expression of TN-C was evaluated by determining the effects of thrombin on PKCepsilon levels and by directly manipulating PKCepsilon levels via the use of antisense oligonucleotides.
BAL fluid from SSc patients contained high levels of TN-C, whereas that from normal subjects contained little or no TN-C. In vitro, SSc lung fibroblasts expressed much higher amounts of TN-C than did normal lung fibroblasts. Consistent with the idea that thrombin is a physiologic inducer of TN-C, thrombin stimulated TN-C mRNA and protein expression in both SSc and normal lung fibroblasts by a mechanism that required proteolytic cleavage of the thrombin receptor. Surprisingly, thrombin treatment and antisense oligonucleotide-mediated depletion of PKCepsilon indicated that TN-C expression is regulated via opposite signaling mechanisms in SSc and normal cells. In SSc lung fibroblasts, thrombin decreased PKCepsilon levels, and the decreased PKCepsilon induced TN-C secretion; in normal fibroblasts, thrombin increased PKCepsilon levels, and the increased PKCepsilon induced TN-C secretion. Normal and SSc lung fibroblasts also differed in the subcellular localization of PKCepsilon, both before and after thrombin treatment.
These studies are the first to demonstrate that thrombin is a potent simulator of TN-C in lung fibroblasts and that PKCepsilon is a critical regulator of TN-C protein levels in these cells. Furthermore, our results indicate that both the regulation of PKCepsilon levels by thrombin and the regulation of TN-C levels by PKCepsilon are defective in SSc lung fibroblasts. |
|---|---|
| AbstractList | To determine whether the extracellular matrix protein tenascin-C (TN-C) is overexpressed in lung fibroblasts from systemic sclerosis (SSc) patients, the molecular mechanisms regulating TN-C secretion in SSc and normal lung fibroblasts, and how these processes might contribute to lung fibrosis in SSc patients.OBJECTIVETo determine whether the extracellular matrix protein tenascin-C (TN-C) is overexpressed in lung fibroblasts from systemic sclerosis (SSc) patients, the molecular mechanisms regulating TN-C secretion in SSc and normal lung fibroblasts, and how these processes might contribute to lung fibrosis in SSc patients.TN-C secretion by SSc and normal fibroblasts was compared in vivo (in bronchoalveolar lavage [BAL] fluid) and in vitro (in culture medium). The ability of thrombin to induce TN-C was confirmed at both the protein and the messenger RNA (mRNA) level. The role of protein kinase Cepsilon (PKCepsilon) in the expression of TN-C was evaluated by determining the effects of thrombin on PKCepsilon levels and by directly manipulating PKCepsilon levels via the use of antisense oligonucleotides.METHODSTN-C secretion by SSc and normal fibroblasts was compared in vivo (in bronchoalveolar lavage [BAL] fluid) and in vitro (in culture medium). The ability of thrombin to induce TN-C was confirmed at both the protein and the messenger RNA (mRNA) level. The role of protein kinase Cepsilon (PKCepsilon) in the expression of TN-C was evaluated by determining the effects of thrombin on PKCepsilon levels and by directly manipulating PKCepsilon levels via the use of antisense oligonucleotides.BAL fluid from SSc patients contained high levels of TN-C, whereas that from normal subjects contained little or no TN-C. In vitro, SSc lung fibroblasts expressed much higher amounts of TN-C than did normal lung fibroblasts. Consistent with the idea that thrombin is a physiologic inducer of TN-C, thrombin stimulated TN-C mRNA and protein expression in both SSc and normal lung fibroblasts by a mechanism that required proteolytic cleavage of the thrombin receptor. Surprisingly, thrombin treatment and antisense oligonucleotide-mediated depletion of PKCepsilon indicated that TN-C expression is regulated via opposite signaling mechanisms in SSc and normal cells. In SSc lung fibroblasts, thrombin decreased PKCepsilon levels, and the decreased PKCepsilon induced TN-C secretion; in normal fibroblasts, thrombin increased PKCepsilon levels, and the increased PKCepsilon induced TN-C secretion. Normal and SSc lung fibroblasts also differed in the subcellular localization of PKCepsilon, both before and after thrombin treatment.RESULTSBAL fluid from SSc patients contained high levels of TN-C, whereas that from normal subjects contained little or no TN-C. In vitro, SSc lung fibroblasts expressed much higher amounts of TN-C than did normal lung fibroblasts. Consistent with the idea that thrombin is a physiologic inducer of TN-C, thrombin stimulated TN-C mRNA and protein expression in both SSc and normal lung fibroblasts by a mechanism that required proteolytic cleavage of the thrombin receptor. Surprisingly, thrombin treatment and antisense oligonucleotide-mediated depletion of PKCepsilon indicated that TN-C expression is regulated via opposite signaling mechanisms in SSc and normal cells. In SSc lung fibroblasts, thrombin decreased PKCepsilon levels, and the decreased PKCepsilon induced TN-C secretion; in normal fibroblasts, thrombin increased PKCepsilon levels, and the increased PKCepsilon induced TN-C secretion. Normal and SSc lung fibroblasts also differed in the subcellular localization of PKCepsilon, both before and after thrombin treatment.These studies are the first to demonstrate that thrombin is a potent simulator of TN-C in lung fibroblasts and that PKCepsilon is a critical regulator of TN-C protein levels in these cells. Furthermore, our results indicate that both the regulation of PKCepsilon levels by thrombin and the regulation of TN-C levels by PKCepsilon are defective in SSc lung fibroblasts.CONCLUSIONThese studies are the first to demonstrate that thrombin is a potent simulator of TN-C in lung fibroblasts and that PKCepsilon is a critical regulator of TN-C protein levels in these cells. Furthermore, our results indicate that both the regulation of PKCepsilon levels by thrombin and the regulation of TN-C levels by PKCepsilon are defective in SSc lung fibroblasts. To determine whether the extracellular matrix protein tenascin-C (TN-C) is overexpressed in lung fibroblasts from systemic sclerosis (SSc) patients, the molecular mechanisms regulating TN-C secretion in SSc and normal lung fibroblasts, and how these processes might contribute to lung fibrosis in SSc patients. TN-C secretion by SSc and normal fibroblasts was compared in vivo (in bronchoalveolar lavage [BAL] fluid) and in vitro (in culture medium). The ability of thrombin to induce TN-C was confirmed at both the protein and the messenger RNA (mRNA) level. The role of protein kinase Cepsilon (PKCepsilon) in the expression of TN-C was evaluated by determining the effects of thrombin on PKCepsilon levels and by directly manipulating PKCepsilon levels via the use of antisense oligonucleotides. BAL fluid from SSc patients contained high levels of TN-C, whereas that from normal subjects contained little or no TN-C. In vitro, SSc lung fibroblasts expressed much higher amounts of TN-C than did normal lung fibroblasts. Consistent with the idea that thrombin is a physiologic inducer of TN-C, thrombin stimulated TN-C mRNA and protein expression in both SSc and normal lung fibroblasts by a mechanism that required proteolytic cleavage of the thrombin receptor. Surprisingly, thrombin treatment and antisense oligonucleotide-mediated depletion of PKCepsilon indicated that TN-C expression is regulated via opposite signaling mechanisms in SSc and normal cells. In SSc lung fibroblasts, thrombin decreased PKCepsilon levels, and the decreased PKCepsilon induced TN-C secretion; in normal fibroblasts, thrombin increased PKCepsilon levels, and the increased PKCepsilon induced TN-C secretion. Normal and SSc lung fibroblasts also differed in the subcellular localization of PKCepsilon, both before and after thrombin treatment. These studies are the first to demonstrate that thrombin is a potent simulator of TN-C in lung fibroblasts and that PKCepsilon is a critical regulator of TN-C protein levels in these cells. Furthermore, our results indicate that both the regulation of PKCepsilon levels by thrombin and the regulation of TN-C levels by PKCepsilon are defective in SSc lung fibroblasts. |
| Author | Ludwicka-Bradley, A Tourkina, E Hoffman, S Fenton, 2nd, J W Lipsitz, S Silver, R M |
| Author_xml | – sequence: 1 givenname: E surname: Tourkina fullname: Tourkina, E organization: Medical University of South Carolina, Charleston 29425, USA – sequence: 2 givenname: S surname: Hoffman fullname: Hoffman, S – sequence: 3 givenname: J W surname: Fenton, 2nd fullname: Fenton, 2nd, J W – sequence: 4 givenname: S surname: Lipsitz fullname: Lipsitz, S – sequence: 5 givenname: R M surname: Silver fullname: Silver, R M – sequence: 6 givenname: A surname: Ludwicka-Bradley fullname: Ludwicka-Bradley, A |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11407697$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1kN9LwzAQx_Og6Db9FyRPog-dd03aNFOEMX8NBgP1faTtVatZUpsOFP95A-rTcZ_78jnuxmzPeUeMaYQpAqQXmKU6ARR4lgIg5OdSzvIrFApms_nyJpk_PqcCrsUUpov1ZZqke2wEADIRmcZDNg7hLbapyMQBO0SUoHKtRuz7hjpLQ-sd9w3vej9Q6_h760wgvqAutDaOInK-3xrLjat5qCz1vqYIuN25F960Ze9La8IQ-KsJ3HedD-1AnJqGqgijYqCorKKIPrueQogbj9h-Y2yg4786YU93t8-Lh2S1vl8u5quky6RK8roETbrKyyoH0xS6KLDGWuWiwkJqiXlR6lJQlck6Q1FDhloVKJEyMqoQE3b6a43HfewoDJttGyqy1jjyu7BRoFGnhYrBk7_grtxSven6dmv6r83_s8QPNu10-A |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1002/1529-0131(200106)44:6<1370::AID-ART230>3.0.CO;2-2 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| ExternalDocumentID | 11407697 |
| Genre | Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article |
| GrantInformation_xml | – fundername: NCRR NIH HHS grantid: RR-1070-1 |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 10A 1CY 1KJ 1L6 1OB 1OC 1ZS 23N 24P 31~ 33P 3O- 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52W 52X 53G 5GY 5RE 66C 6J9 6P2 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAQQT AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACMXC ACPOU ACRPL ACSCC ACXBN ACXQS ACYXJ ADBTR ADEOM ADIZJ ADMGS ADNMO ADOZA ADZCM ADZOD AEEZP AEIGN AEIMD AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AI. AIACR AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZFZN BDRZF BROTX BRXPI BY8 C45 CGR CS3 CUY CVF D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM EBS ECM EIF EJD EMOBN EX3 F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J5H JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LSO LUTES LW6 LYRES M65 MEWTI MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NNB NPM OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q11 QB0 QRW RGB RIWAO RJQFR ROL RWI RX1 RXW RYL SAMSI SJN SUPJJ SV3 TAE TEORI TWZ UB1 V2E V8K V9Y VH1 VXZ W8V WH7 WIB WIH WIJ WIK WIN WJL WOW WQJ WRC WUP WXI WXSBR X6Y X7M XG1 XPP XV2 YFH YOC ZGI ZXP ZZTAW ~IA ~WT 7X8 AAFWJ AAMMB AEFGJ AGQPQ AGXDD AGYGG AIDQK AIDYY |
| ID | FETCH-LOGICAL-p547-6db09e9c6bc60af89881d1d763c18494168b9b3ec54d513d051978141e5ea783 |
| ISSN | 0004-3591 |
| IngestDate | Thu Sep 04 20:01:25 EDT 2025 Wed Feb 19 01:23:47 EST 2025 |
| IsPeerReviewed | false |
| IsScholarly | false |
| Issue | 6 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-p547-6db09e9c6bc60af89881d1d763c18494168b9b3ec54d513d051978141e5ea783 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 11407697 |
| PQID | 70919287 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_70919287 pubmed_primary_11407697 |
| PublicationCentury | 2000 |
| PublicationDate | 2001-Jun 20010601 |
| PublicationDateYYYYMMDD | 2001-06-01 |
| PublicationDate_xml | – month: 06 year: 2001 text: 2001-Jun |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Arthritis and rheumatism |
| PublicationTitleAlternate | Arthritis Rheum |
| PublicationYear | 2001 |
| SSID | ssj0002353 |
| Score | 1.2937822 |
| Snippet | To determine whether the extracellular matrix protein tenascin-C (TN-C) is overexpressed in lung fibroblasts from systemic sclerosis (SSc) patients, the... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1370 |
| SubjectTerms | Blotting, Northern Bronchoalveolar Lavage Fluid - chemistry Bronchoalveolar Lavage Fluid - cytology Cells, Cultured Dose-Response Relationship, Drug Enzyme-Linked Immunosorbent Assay Fibroblasts - enzymology Humans Isoenzymes - antagonists & inhibitors Isoenzymes - deficiency Isoenzymes - genetics Lung - cytology Lung - enzymology Oligonucleotides, Antisense - pharmacology Protein Kinase C - antagonists & inhibitors Protein Kinase C - deficiency Protein Kinase C - genetics Protein Kinase C-epsilon RNA, Messenger - metabolism Scleroderma, Systemic - enzymology Scleroderma, Systemic - pathology Signal Transduction Tenascin - analysis Tenascin - biosynthesis Tenascin - genetics Thrombin - pharmacology |
| Title | Depletion of protein kinase Cepsilon in normal and scleroderma lung fibroblasts has opposite effects on tenascin expression |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/11407697 https://www.proquest.com/docview/70919287 |
| Volume | 44 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0004-3591 databaseCode: DR2 dateStart: 19990101 customDbUrl: isFulltext: true dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002353 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ra9swEBdZB2Vfxt7ruoc-LGPDOI0tWZayMciSlKykLWwp5FvwQ6Zhre0l9pftb9n_upMlO-4e7AHBGBGZs-4X6e5y9zuEnscx77PYg993QJhNnZDbcM57NuMyCgLuJVGoqpGPT9j0jB4tvEWn862VtVQWYS_68su6kv_RKoyBXlWV7D9otnkoDMA96BeuoGG4_pWOxzJX3Nna5KsYF1ap9WmVwslkjWS-WV3oRMZUGaaaE2ADj1ir_meXgXVRqixK8JezEGzoQjVW2VhZXuVxtTI9Ugvs6gCOyqofgM6bTdtG7XBdnFfcSDpZ_VyWygw21IRVBLtUEfngSuHDNEuSH6OvsLgmm__IamI_sxW8SNV11nyxjlG0cqmafZfaxNN9uep9V_M-Gny1N1GH6F4iP-3umi0WLA6V4kVgp-du5dN2XUEpqIZ1yUhNhlv4DN-PbXAKwMfqkgnp9Xuj0y5555pqyyvM2yeny8Oz2Ww5nyzmL_LPtmpKppbadGi5hq67cGioziDjD1t2MpcYklPzcrtIGCkPGhlfaglfUTpgb5Rsg8FWrrdaqtcg0-8dnMrQmd9CN42HgocabrdRR6Z30O6xycG4i742qMNZgg3qsEYdrlGHYUijDgMmcAt1WKEOt1CHAXW4Rh02qMPwiBp1eIu6e-jj4WQ-mtqmhYede9S3WRz2hRQRCyPWDxIuOLhHTgxnWuRwKsAZ4KEIiYw8GnsOiZU_oTjYHOnJwOfkPtpJs1Q-RDjhTEVM_QjMUwpTBGfci4LQ5QI88kTsoWf1-i1hg1T_egWpzMrN0geLWLjc30MP9LIuc83jogry-z4T_qM_zt1HN7awfox2inUpn4AxWoRPK0h8B4DPhlo |
| linkProvider | Wiley-Blackwell |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Depletion+of+protein+kinase+Cepsilon+in+normal+and+scleroderma+lung+fibroblasts+has+opposite+effects+on+tenascin+expression&rft.jtitle=Arthritis+and+rheumatism&rft.au=Tourkina%2C+E&rft.au=Hoffman%2C+S&rft.au=Fenton%2C+J+W&rft.au=Lipsitz%2C+S&rft.date=2001-06-01&rft.issn=0004-3591&rft.volume=44&rft.issue=6&rft.spage=1370&rft_id=info:doi/10.1002%2F1529-0131%28200106%2944%3A6%3C1370%3A%3AAID-ART230%3E3.0.CO%3B2-2&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-3591&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-3591&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-3591&client=summon |